Ideation and implementation of an open science drug discovery business model – M4K Pharma
This paper was originally published by Maxwell Robert Morgan, Owen Gwilym Roberts, and Aled Morgan Edwards in Wellcome Open Res […]
Obviousness-Type Double Patenting Just Became Less of a Problem for Innovators
This is a guest post from Pepper Hamilton Partners John P. Isacson and N. Nicole Stakleff. John can be contacted
Obviousness-Type Double Patenting Just Became Less of a Problem for Innovators Read Post »
A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals
This article was originally published by Arun Kumar, Sandeep Kumar, and Arun Nanda in Adv Pharm Bull. 2018 Aug; 8(3): 355–363 under
A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals Read Post »
Drug Repositioning: Concept, Classification, Methodology, and Importance in Rare/Orphans and Neglected Diseases
This paper was originally published by Emanuel Almeida Moreira de Oliveira and Karen Luise Lang in Journal of Applied Pharmaceutical Science Vol.
Try our one-month starter plans
Do you want an easier way to access DrugPatentWatch without a long-term commitment? We have monthly starter plans designed for short-term
PBMs, Formularies, and Rebates: What Investors Should Know
There is no simple way to explain drug prices, particularly in the US market, where drug prices vary considerably more
PBMs, Formularies, and Rebates: What Investors Should Know Read Post »
The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review
This article was originally published by Gerard T. Vondeling, Qi Cao, Maarten J. Postma, and Mark H. Rozenbaum in Applied Health
The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review Read Post »
Clause 8 Podcast Interview with Co-Author of the Hatch-Waxman Act
Former Congressman Henry Waxman was recently interviewed for the Clause 8 podcast about how he worked together with Sen. Orrin
Clause 8 Podcast Interview with Co-Author of the Hatch-Waxman Act Read Post »
3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges
This paper was originally published by Witold Jamróz, Joanna Szafraniec, Mateusz Kurek, and Renata Jachowicz in Pharmaceutical Research September 2018, 35:176 under
